FDA approval sees Orthocell's Remplir enter multi-billion dollar US nerve market

By Proactive Investors / April 07, 2025 / www.youtube.com / Article Link


Orthocell Ltd chairman John van der Wielen talked with Proactive about the company receiving FDA clearance for its nerve repair ...

Recent News

Gold stocks outperform equities surge

May 11, 2026 / www.canadianminingreport.com

Global tech once again leading the markets in 2026

May 11, 2026 / www.canadianminingreport.com

Gold stocks decline as equities reach all-time highs

May 04, 2026 / www.canadianminingreport.com

Gold stocks decline on metal pullback

April 27, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok